The Silent Threat: Understanding Malignant Hyperthermia After the Tragic Loss of Nicolas Gigot
A rare and often rapidly fatal condition, malignant hyperthermia (MH) remains largely unknown to the general public, despite claiming the life of 19-year-old Belgian rugby player Nicolas Gigot in 2020. His case, and the subsequent founding of the Nicolas Gigot Foundation, has brought renewed attention to this devastating medical emergency.
The death of the young athlete, who collapsed during training on June 16, 2020, in Bourgoin-Jallieu, France, highlighted the brutal speed at which MH can progress. Gigot’s ordeal, as recounted by his mother Nadine Brialmont, involved a terrifying cascade of organ failure, ultimately requiring the amputation of both legs before his death a few days later. “Nicolas had hyperthermia,” Brialmont testified. “His body gave out. Then began a 33-day ordeal. He lost his kidneys, his liver, and both his legs had to be amputated.” But perhaps the most harrowing aspect, she shared, was his conscious suffering, “locked in his body… unable to scream, to protest, to say that he loved us.” From this profound loss, the Nicolas Gigot Foundation was born, dedicated to providing communication tools for those who have lost the ability to speak.
Malignant hyperthermia of exertion, the form that tragically affected Gigot, differs significantly from common heatstroke caused by heatwaves or dehydration. While heatstroke develops over time, MH is characterized by a sudden and dramatic rise in body temperature, leaving little time for intervention. However, exertional MH isn’t the only manifestation of this dangerous condition. Medicinal malignant hyperthermia, a feared complication of general anesthesia, and reactions to certain drugs or medications, can also trigger the same life-threatening physiological response.
The underlying mechanism in all forms of MH is a runaway increase in body temperature, often exceeding 41°C (105.8°F), leading to a cascade of potentially fatal reactions. The body’s natural temperature regulation system, which relies on sweating and blood circulation to dissipate heat, is overwhelmed when heat production surpasses cooling capacity. Above 40°C, proteins begin to degrade, cells suffer damage, and vital organs are threatened.
Classic Hyperthermia: A Gradual Threat
The most common form of hyperthermia occurs during periods of intense heat, prolonged exercise, or sun exposure. Initial symptoms include intense fatigue, headaches, cramps, and excessive sweating, which can paradoxically give way to a reduction in perspiration as the body becomes exhausted. Prompt hydration and cooling can usually control this type of hyperthermia, but emergency rooms see numerous severe cases each summer, particularly among vulnerable populations like children, the elderly, and outdoor workers.
Malignant Hyperthermia: The Speed of Crisis
Medicinal and anesthetic hyperthermia are less common, triggered in general anesthesia by specific substances – including gaseous anesthetics and muscle relaxants – activating an abnormal reaction in genetically predisposed patients. The muscles contract continuously, generating immense heat and causing a rapid rise in body temperature. This is accompanied by increased CO₂ levels, a racing heart, muscle contractures, dark urine due to muscle breakdown, and a risk of cardiac arrest.
This form of MH isn’t limited to the operating room. Stimulant drugs like amphetamines, ecstasy (MDMA), cocaine, and even certain antidepressants and neuroleptics can induce hyperthermia syndromes, especially when combined with exercise and high temperatures. Cases frequently occur at nightclubs and festivals, where the nervous system is overstimulated, muscles overheat, and temperatures soar. Treatment involves immediately stopping the substance, aggressive cooling, and, in a hospital setting, administering dantrolene, the only known antidote.
Malignant exertional hyperthermia in athletes, like in the case of Nicolas Gigot, can develop just as quickly in a previously healthy individual. It often begins with subtle signs – weakness, disorientation, slurred speech – before leading to collapse and potentially loss of consciousness. Internal temperatures can exceed 42°C (107.6°F), releasing toxins into the bloodstream and causing kidney and heart failure. Every minute of delay in treatment diminishes the chances of survival, requiring immediate cooling, hydration, and emergency medical assistance.
Why is Malignant Hyperthermia So Feared?
The critical difference between classic hyperthermia and malignant hyperthermia lies in its speed. Once the reaction begins, the internal temperature rises uncontrollably, causing blood to become acidic, organs to fail, and cells to be destroyed. Without intervention, multiorgan failure can occur in less than an hour.
Dantrolene remains the only effective treatment to halt the muscular reaction in anesthetic and medicinal forms of MH, and must be readily available in every operating room. In sporting or festive contexts, cooling measures and immediate medical attention are crucial while awaiting hospital treatment. The most dangerous mistake is to dismiss early symptoms as mere discomfort.
Prevention is Paramount
Preventing malignant exertional hyperthermia in athletes begins with listening to the body. Regular hydration, adapting training to high heat conditions, frequent breaks, and avoiding strenuous activity during peak temperatures are essential. Some professional sports teams utilize cold baths and monitor player temperatures during intense sessions to facilitate rapid cooling. Educating coaches and supervisors to recognize warning signs – confusion, incoherent speech, cessation of sweating, and abnormal gait – and to halt exertion immediately is vital.
In anesthesia, prevention focuses on identifying at-risk individuals through family history and genetic testing. Operating rooms must have dantrolene readily available, and staff must be trained to respond urgently to early signs like a sudden rise in CO₂, muscle contractures, and rapid fever.
The dangers associated with drug-induced hyperthermia are often underestimated. Stimulants, when combined with exertion and heat, can trigger severe overheating. Taking breaks, staying hydrated, seeking fresh air, and calling for help at the first sign of incoherent behavior or extreme agitation can be life-saving.
The Nicolas Gigot Foundation exemplifies the enduring legacy of a tragic loss, working to empower those deprived of speech through the provision of assistive communication devices, such as Tobii devices, which utilize eye-tracking technology. A Tobii device will be donated to the Croix-Rousse hospital (Hospices Civils de Lyon) on December 11, 2025, by the foundation.
The story of Nicolas Gigot serves as a stark reminder of the silent threat posed by malignant hyperthermia and the critical importance of awareness, preparedness, and rapid response.
